These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2324539)

  • 21. T-cell activation and induction of antibodies and memory T cells by immunization with inactivated Japanese encephalitis vaccine.
    Aihara H; Takasaki T; Toyosaki-Maeda T; Suzuki R; Okuno Y; Kurane I
    Viral Immunol; 2000; 13(2):179-86. PubMed ID: 10892998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose-response effectiveness and extended safety testing in rhesus monkeys.
    Monath TP; Levenbook I; Soike K; Zhang ZX; Ratterree M; Draper K; Barrett AD; Nichols R; Weltzin R; Arroyo J; Guirakhoo F
    J Virol; 2000 Feb; 74(4):1742-51. PubMed ID: 10644345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Further experience with Japanese encephalitis vaccine.
    Sanchez JL; Hoke CH; McCown J; DeFraites RF; Takafuji ET; Diniega BM; Pang LW
    Lancet; 1990 Apr; 335(8695):972-3. PubMed ID: 1970043
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunogenicity of low dose Japanese encephalitis vaccine (BIKEN) administered by the intradermal route: preliminary data.
    Intralawan P; Paupunwatana S
    Asian Pac J Allergy Immunol; 1993 Jun; 11(1):79-83. PubMed ID: 8216563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cross-protection elicited by primary and booster vaccinations against Japanese encephalitis: a two-year follow-up study.
    Erra EO; Askling HH; Yoksan S; Rombo L; Riutta J; Vene S; Lindquist L; Vapalahti O; Kantele A
    Vaccine; 2013 Dec; 32(1):119-23. PubMed ID: 24176496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Product review on the JE vaccine IXIARO.
    Firbas C; Jilma B
    Hum Vaccin Immunother; 2015; 11(2):411-20. PubMed ID: 25621812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An inactivated Ross River virus vaccine is well tolerated and immunogenic in an adult population in a randomized phase 3 trial.
    Wressnigg N; van der Velden MV; Portsmouth D; Draxler W; O'Rourke M; Richmond P; Hall S; McBride WJ; Redfern A; Aaskov J; Barrett PN; Aichinger G
    Clin Vaccine Immunol; 2015 Mar; 22(3):267-73. PubMed ID: 25540268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Japanese encephalitis virus-specific proliferative responses of human peripheral blood T lymphocytes.
    Konishi E; Kurane I; Mason PW; Innis BL; Ennis FA
    Am J Trop Med Hyg; 1995 Sep; 53(3):278-83. PubMed ID: 7573713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of pregnancy on protection of mice immunized by Japanese encephalitis virus & its experimental inactivated vaccine.
    Soni GR
    Indian J Med Res; 1994 Aug; 100():57-8. PubMed ID: 7927555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of effectiveness of mouse brain inactivated Japanese encephalitis vaccine produced in India.
    Gowal D; Tahlan AK
    Indian J Med Res; 1995 Dec; 102():267-71. PubMed ID: 8557319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunogenicity of wild-type and vaccine strains of Japanese encephalitis virus and the effect of haplotype restriction on murine immune responses.
    Wills MR; Singh BK; Debnath NC; Barrett AD
    Vaccine; 1993; 11(7):761-6. PubMed ID: 8342323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. One-year immunogenicity kinetics and safety of a purified chick embryo cell rabies vaccine and an inactivated Vero cell-derived Japanese encephalitis vaccine administered concomitantly according to a new, 1-week, accelerated primary series.
    Cramer JP; Jelinek T; Paulke-Korinek M; Reisinger EC; Dieckmann S; Alberer M; Bühler S; Bosse D; Meyer S; Fragapane E; Costantini M; Pellegrini M; Lattanzi M; Dovali C
    J Travel Med; 2016 Mar; 23(3):. PubMed ID: 26994987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Japanese encephalitis vaccine-facilitated dengue virus infection-enhancement antibody in adults.
    Saito Y; Moi ML; Takeshita N; Lim CK; Shiba H; Hosono K; Saijo M; Kurane I; Takasaki T
    BMC Infect Dis; 2016 Oct; 16(1):578. PubMed ID: 27756212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Japanese encephalitis vaccines.
    Wkly Epidemiol Rec; 1998 Oct; 73(44):337-44. PubMed ID: 9817024
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparing the immunogenicity and safety of 3 Japanese encephalitis vaccines in Asia-Pacific area: A systematic review and meta-analysis.
    Wang SY; Cheng XH; Li JX; Li XY; Zhu FC; Liu P
    Hum Vaccin Immunother; 2015; 11(6):1418-25. PubMed ID: 25915588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Superior immunogenicity of a freeze-dried, cell culture-derived Japanese encephalitis vaccine (inactivated).
    Kikukawa A; Gomi Y; Akechi M; Onishi T; Manabe S; Namazue J; Fuke I; Ishikawa T; Okuno Y; Ueda S
    Vaccine; 2012 Mar; 30(13):2329-35. PubMed ID: 22306856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Failure of Japanese encephalitis vaccine and infection in inducing neutralizing antibodies against West Nile virus, People's Republic of China.
    Tang F; Zhang JS; Liu W; Zhao QM; Zhang F; Wu XM; Yang H; Ly H; Cao WC
    Am J Trop Med Hyg; 2008 Jun; 78(6):999-1001. PubMed ID: 18541783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunogenicity of one dose of Vero cell culture-derived Japanese encephalitis (JE) vaccine in adults previously vaccinated with mouse brain-derived JE vaccine.
    Woolpert T; Staples JE; Faix DJ; Nett RJ; Kosoy OI; Biggerstaff BJ; Johnson BW; Sracic M; Fischer M
    Vaccine; 2012 Apr; 30(20):3090-6. PubMed ID: 22406277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recommendations for use of a booster dose of inactivated vero cell culture-derived Japanese encephalitis vaccine: advisory committee on immunization practices, 2011.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 May; 60(20):661-3. PubMed ID: 21617632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An efficient method for production of purified inactivated Japanese encephalitis vaccine from mouse brains.
    Gupta RK; Misra CN; Gupta VK; Saxena SN
    Vaccine; 1991 Dec; 9(12):865-7. PubMed ID: 1811372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.